Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | +2.54% | +1.51% | +12.22% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 50.12M |
---|---|---|---|---|---|
Net income 2024 * | -53M | Net income 2025 * | -74M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.39
x | P/E ratio 2025 * |
-2.24
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.57% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +2.54% | ||
1 week | +1.51% | ||
Current month | -1.94% | ||
1 month | -2.42% | ||
3 months | +11.60% | ||
6 months | +41.26% | ||
Current year | +12.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven N. Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John S. McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.02 | +2.54% | 67,382 |
24-04-24 | 1.97 | -8.80% | 100,805 |
24-04-23 | 2.16 | +6.93% | 190,023 |
24-04-22 | 2.02 | +8.60% | 313,628 |
24-04-19 | 1.86 | -6.53% | 420,856 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.22% | 50.12M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- ELDN Stock